In early June this year, I have diagnosed with CML and I am on Dasatinib 100mg. About a week ago, I got my 3 months BCR-ABL measurements, in the peripheral blood, from 2 different labs (and two different countries) verifying that I've achieved MMR which based on the guidelines is a very good result. So far everything was great.
As a part of my 3-months tests, I had a bone marrow biopsy as well. Few days ago I received the bone marrow results, where in my surprise it mentions that out of 20 mitigations that have been analysed one had the Ph+ mutation. Does this mean that I haven't achieved CCyR? Or I was unlucky enough the test to "select" and analyse a 1 molecule out of 1000 that has the mutation (since MMR is 0.1% or better). Having less 1% of BCR-ABL in the peripheral blood means that you are expecting the bone marrow to be clear?
Looking forward for your thoughts.